 | • レポートコード：GIR-107A14488 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、マイトジェン活性化プロテインキナーゼ1のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。マイトジェン活性化プロテインキナーゼ1の種類別市場規模（CB-745、JRP-890、KO-947、LY-3214996、その他）、用途別市場規模（膵管腺がん、固形腫瘍、結腸がん、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・マイトジェン活性化プロテインキナーゼ1の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aeterna Zentaris Inc.、AGV Discovery, SAS、Asana BioSciences, LLC、Genentech, Inc.、Kura Oncology, Inc.、Laurent Pharmaceuticals Inc.、Merck & Co., Inc.、Merck KGaA ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CB-745、JRP-890、KO-947、LY-3214996、その他 ・用途別分析2016年-2026年：膵管腺がん、固形腫瘍、結腸がん、乳がん、その他 ・マイトジェン活性化プロテインキナーゼ1の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・マイトジェン活性化プロテインキナーゼ1のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・マイトジェン活性化プロテインキナーゼ1のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・マイトジェン活性化プロテインキナーゼ1の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・マイトジェン活性化プロテインキナーゼ1の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Mitogen Activated Protein Kinase 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Mitogen Activated Protein Kinase 1 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Mitogen Activated Protein Kinase 1 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Mitogen Activated Protein Kinase 1 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CB-745
JRP-890
KO-947
LY-3214996
Others
Market segment by Application can be divided into
Pancreatic Ductal Adenocarcinoma
Solid Tumor
Colon Cancer
Breast Cancer
Others
The key market players for global Mitogen Activated Protein Kinase 1 market are listed below:
Aeterna Zentaris Inc.
AGV Discovery, SAS
Asana BioSciences, LLC
Genentech, Inc.
Kura Oncology, Inc.
Laurent Pharmaceuticals Inc.
Merck & Co., Inc.
Merck KGaA
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Mitogen Activated Protein Kinase 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mitogen Activated Protein Kinase 1, with price, sales, revenue and global market share of Mitogen Activated Protein Kinase 1 from 2019 to 2021.
Chapter 3, the Mitogen Activated Protein Kinase 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mitogen Activated Protein Kinase 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Mitogen Activated Protein Kinase 1 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Mitogen Activated Protein Kinase 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Mitogen Activated Protein Kinase 1 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mitogen Activated Protein Kinase 1 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 CB-745
1.2.3 JRP-890
1.2.4 KO-947
1.2.5 LY-3214996
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Mitogen Activated Protein Kinase 1 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pancreatic Ductal Adenocarcinoma
1.3.3 Solid Tumor
1.3.4 Colon Cancer
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Mitogen Activated Protein Kinase 1 Market Size & Forecast
1.4.1 Global Mitogen Activated Protein Kinase 1 Sales in Value (2016-2026))
1.4.2 Global Mitogen Activated Protein Kinase 1 Sales in Volume (2016-2026)
1.4.3 Global Mitogen Activated Protein Kinase 1 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Mitogen Activated Protein Kinase 1 Production Capacity Analysis
1.5.1 Global Mitogen Activated Protein Kinase 1 Total Production Capacity (2016-2026)
1.5.2 Global Mitogen Activated Protein Kinase 1 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mitogen Activated Protein Kinase 1 Market Drivers
1.6.2 Mitogen Activated Protein Kinase 1 Market Restraints
1.6.3 Mitogen Activated Protein Kinase 1 Trends Analysis
2 Manufacturers Profiles
2.1 Aeterna Zentaris Inc.
2.1.1 Aeterna Zentaris Inc. Details
2.1.2 Aeterna Zentaris Inc. Major Business
2.1.3 Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Product and Services
2.1.4 Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AGV Discovery, SAS
2.2.1 AGV Discovery, SAS Details
2.2.2 AGV Discovery, SAS Major Business
2.2.3 AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Product and Services
2.2.4 AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Asana BioSciences, LLC
2.3.1 Asana BioSciences, LLC Details
2.3.2 Asana BioSciences, LLC Major Business
2.3.3 Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Product and Services
2.3.4 Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Genentech, Inc.
2.4.1 Genentech, Inc. Details
2.4.2 Genentech, Inc. Major Business
2.4.3 Genentech, Inc. Mitogen Activated Protein Kinase 1 Product and Services
2.4.4 Genentech, Inc. Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Kura Oncology, Inc.
2.5.1 Kura Oncology, Inc. Details
2.5.2 Kura Oncology, Inc. Major Business
2.5.3 Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Product and Services
2.5.4 Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Laurent Pharmaceuticals Inc.
2.6.1 Laurent Pharmaceuticals Inc. Details
2.6.2 Laurent Pharmaceuticals Inc. Major Business
2.6.3 Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Product and Services
2.6.4 Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business
2.7.3 Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Product and Services
2.7.4 Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merck KGaA
2.8.1 Merck KGaA Details
2.8.2 Merck KGaA Major Business
2.8.3 Merck KGaA Mitogen Activated Protein Kinase 1 Product and Services
2.8.4 Merck KGaA Mitogen Activated Protein Kinase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Mitogen Activated Protein Kinase 1 Sales by Manufacturer
3.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Mitogen Activated Protein Kinase 1 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Mitogen Activated Protein Kinase 1
3.4 Market Concentration Rate
3.4.1 Top 3 Mitogen Activated Protein Kinase 1 Manufacturer Market Share
3.4.2 Top 6 Mitogen Activated Protein Kinase 1 Manufacturer Market Share
3.5 Global Mitogen Activated Protein Kinase 1 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Mitogen Activated Protein Kinase 1 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mitogen Activated Protein Kinase 1 Market Size by Region
4.1.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Region (2016-2026)
4.1.2 Global Mitogen Activated Protein Kinase 1 Revenue by Region (2016-2026)
4.2 North America Mitogen Activated Protein Kinase 1 Revenue (2016-2026)
4.3 Europe Mitogen Activated Protein Kinase 1 Revenue (2016-2026)
4.4 Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue (2016-2026)
4.5 South America Mitogen Activated Protein Kinase 1 Revenue (2016-2026)
4.6 Middle East and Africa Mitogen Activated Protein Kinase 1 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Type (2016-2026)
5.2 Global Mitogen Activated Protein Kinase 1 Revenue by Type (2016-2026)
5.3 Global Mitogen Activated Protein Kinase 1 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Mitogen Activated Protein Kinase 1 Sales in Volume by Application (2016-2026)
6.2 Global Mitogen Activated Protein Kinase 1 Revenue by Application (2016-2026)
6.3 Global Mitogen Activated Protein Kinase 1 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Mitogen Activated Protein Kinase 1 Sales by Type (2016-2026)
7.2 North America Mitogen Activated Protein Kinase 1 Sales by Application (2016-2026)
7.3 North America Mitogen Activated Protein Kinase 1 Market Size by Country
7.3.1 North America Mitogen Activated Protein Kinase 1 Sales in Volume by Country (2016-2026)
7.3.2 North America Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Mitogen Activated Protein Kinase 1 Sales by Type (2016-2026)
8.2 Europe Mitogen Activated Protein Kinase 1 Sales by Application (2016-2026)
8.3 Europe Mitogen Activated Protein Kinase 1 Market Size by Country
8.3.1 Europe Mitogen Activated Protein Kinase 1 Sales in Volume by Country (2016-2026)
8.3.2 Europe Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Type (2016-2026)
9.2 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Application (2016-2026)
9.3 Asia-Pacific Mitogen Activated Protein Kinase 1 Market Size by Region
9.3.1 Asia-Pacific Mitogen Activated Protein Kinase 1 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Mitogen Activated Protein Kinase 1 Sales by Type (2016-2026)
10.2 South America Mitogen Activated Protein Kinase 1 Sales by Application (2016-2026)
10.3 South America Mitogen Activated Protein Kinase 1 Market Size by Country
10.3.1 South America Mitogen Activated Protein Kinase 1 Sales in Volume by Country (2016-2026)
10.3.2 South America Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Type (2016-2026)
11.2 Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Application (2016-2026)
11.3 Middle East & Africa Mitogen Activated Protein Kinase 1 Market Size by Country
11.3.1 Middle East & Africa Mitogen Activated Protein Kinase 1 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Mitogen Activated Protein Kinase 1 Typical Distributors
12.3 Mitogen Activated Protein Kinase 1 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Mitogen Activated Protein Kinase 1 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Mitogen Activated Protein Kinase 1 Revenue by Application, (USD Million), 2021-2026
Table 3. Aeterna Zentaris Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Aeterna Zentaris Inc. Major Business
Table 5. Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Product and Services
Table 6. Aeterna Zentaris Inc. Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AGV Discovery, SAS Basic Information, Manufacturing Base and Competitors
Table 8. AGV Discovery, SAS Major Business
Table 9. AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Product and Services
Table 10. AGV Discovery, SAS Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Asana BioSciences, LLC Basic Information, Manufacturing Base and Competitors
Table 12. Asana BioSciences, LLC Major Business
Table 13. Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Product and Services
Table 14. Asana BioSciences, LLC Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Genentech, Inc. Major Business
Table 17. Genentech, Inc. Mitogen Activated Protein Kinase 1 Product and Services
Table 18. Genentech, Inc. Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Kura Oncology, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Kura Oncology, Inc. Major Business
Table 21. Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Product and Services
Table 22. Kura Oncology, Inc. Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Laurent Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Laurent Pharmaceuticals Inc. Major Business
Table 25. Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Product and Services
Table 26. Laurent Pharmaceuticals Inc. Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co., Inc. Major Business
Table 29. Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Product and Services
Table 30. Merck & Co., Inc. Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 32. Merck KGaA Major Business
Table 33. Merck KGaA Mitogen Activated Protein Kinase 1 Product and Services
Table 34. Merck KGaA Mitogen Activated Protein Kinase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Mitogen Activated Protein Kinase 1 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Mitogen Activated Protein Kinase 1 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Mitogen Activated Protein Kinase 1, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Mitogen Activated Protein Kinase 1 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Mitogen Activated Protein Kinase 1 Production Site of Key Manufacturer
Table 40. Mitogen Activated Protein Kinase 1 New Entrant and Capacity Expansion Plans
Table 41. Mitogen Activated Protein Kinase 1 Mergers & Acquisitions in the Past Five Years
Table 42. Global Mitogen Activated Protein Kinase 1 Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Mitogen Activated Protein Kinase 1 Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Mitogen Activated Protein Kinase 1 Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Mitogen Activated Protein Kinase 1 Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Mitogen Activated Protein Kinase 1 Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Mitogen Activated Protein Kinase 1 Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Mitogen Activated Protein Kinase 1 Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Mitogen Activated Protein Kinase 1 Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Mitogen Activated Protein Kinase 1 Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Mitogen Activated Protein Kinase 1 Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Mitogen Activated Protein Kinase 1 Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Mitogen Activated Protein Kinase 1 Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Mitogen Activated Protein Kinase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Mitogen Activated Protein Kinase 1 Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Mitogen Activated Protein Kinase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Mitogen Activated Protein Kinase 1 Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Mitogen Activated Protein Kinase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Mitogen Activated Protein Kinase 1 Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Mitogen Activated Protein Kinase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Mitogen Activated Protein Kinase 1 Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Mitogen Activated Protein Kinase 1 Typical Distributors
Table 101. Mitogen Activated Protein Kinase 1 Typical Customers
List of Figures
Figure 1. Mitogen Activated Protein Kinase 1 Picture
Figure 2. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Type in 2020
Figure 3. CB-745
Figure 4. JRP-890
Figure 5. KO-947
Figure 6. LY-3214996
Figure 7. Others
Figure 8. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Application in 2020
Figure 9. Pancreatic Ductal Adenocarcinoma
Figure 10. Solid Tumor
Figure 11. Colon Cancer
Figure 12. Breast Cancer
Figure 13. Others
Figure 14. Global Mitogen Activated Protein Kinase 1 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Mitogen Activated Protein Kinase 1 Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Mitogen Activated Protein Kinase 1 Sales (2016-2026) & (K Pcs)
Figure 17. Global Mitogen Activated Protein Kinase 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Mitogen Activated Protein Kinase 1 Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Mitogen Activated Protein Kinase 1 Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Mitogen Activated Protein Kinase 1 Market Drivers
Figure 21. Mitogen Activated Protein Kinase 1 Market Restraints
Figure 22. Mitogen Activated Protein Kinase 1 Market Trends
Figure 23. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Manufacturer in 2020
Figure 24. Global Mitogen Activated Protein Kinase 1 Revenue Market Share by Manufacturer in 2020
Figure 25. Mitogen Activated Protein Kinase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Mitogen Activated Protein Kinase 1 Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Mitogen Activated Protein Kinase 1 Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Region (2016-2026)
Figure 29. Global Mitogen Activated Protein Kinase 1 Revenue Market Share by Region (2016-2026)
Figure 30. North America Mitogen Activated Protein Kinase 1 Revenue (2016-2026) & (USD Million)
Figure 31. Europe Mitogen Activated Protein Kinase 1 Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue (2016-2026) & (USD Million)
Figure 33. South America Mitogen Activated Protein Kinase 1 Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Mitogen Activated Protein Kinase 1 Revenue (2016-2026) & (USD Million)
Figure 35. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Type (2016-2026)
Figure 36. Global Mitogen Activated Protein Kinase 1 Revenue Market Share by Type (2016-2026)
Figure 37. Global Mitogen Activated Protein Kinase 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 39. Global Mitogen Activated Protein Kinase 1 Revenue Market Share by Application (2016-2026)
Figure 40. Global Mitogen Activated Protein Kinase 1 Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Mitogen Activated Protein Kinase 1 Sales Market Share by Type (2016-2026)
Figure 42. North America Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 43. North America Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2016-2026)
Figure 44. North America Mitogen Activated Protein Kinase 1 Revenue Market Share by Country (2016-2026)
Figure 45. United States Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Mitogen Activated Protein Kinase 1 Sales Market Share by Type (2016-2026)
Figure 49. Europe Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 50. Europe Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2016-2026)
Figure 51. Europe Mitogen Activated Protein Kinase 1 Revenue Market Share by Country (2016-2026)
Figure 52. Germany Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Mitogen Activated Protein Kinase 1 Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Mitogen Activated Protein Kinase 1 Revenue Market Share by Region (2016-2026)
Figure 61. China Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Mitogen Activated Protein Kinase 1 Sales Market Share by Type (2016-2026)
Figure 68. South America Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 69. South America Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2016-2026)
Figure 70. South America Mitogen Activated Protein Kinase 1 Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Mitogen Activated Protein Kinase 1 Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Mitogen Activated Protein Kinase 1 Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Mitogen Activated Protein Kinase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の二重特異性プロテインキナーゼTTK市場 2021：企業別、地域別、種類・用途別 The Dual Specificity Protein Kinase TTK market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界のセリンプロテインキナーゼ市場 2021：企業別、地域別、種類・用途別 The Serine Protein Kinase market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のチロシンプロテインキナーゼITK市場 2021：企業別、地域別、種類・用途別 The Tyrosine Protein Kinase ITK market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界のチロシンプロテインキナーゼJAK1市場 2021：企業別、地域別、種類・用途別 The Tyrosine Protein Kinase JAK1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の二重特異性チロシンリン酸化調節キナーゼ1A市場 2021：企業別、地域別、種類・用途別 The Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…